SCHEMBL5809339

SCHEMBL5809339

C=Cc1cccnc1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7216828 0.77 — —
SCHEMBL3439424 0.77 — —
SCHEMBL18327727 0.77 — —
SCHEMBL29999963 0.77 — —
SCHEMBL24179779 0.76 ALDH1A1 (0.41) —
SCHEMBL93457 0.74 ALDH1A1 (0.39) —
SCHEMBL29554163 0.74 ALDH1A1 (0.39) —
SCHEMBL12087690 0.74 — —
SCHEMBL20070416 0.74 KDM4E (0.36) —
SCHEMBL11055199 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050276781-A1 Molecularly imprinted phosphate binders for therapeutic use UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. 2005-12-15 — — US claimed
EP-2958562-B1 ANTIDIABETIC BICYCLIC COMPOUNDS MERCK SHARP & DOHME LLC (US) 2025-09-10 — — EP disclosed
US-20190000860-A1 USE OF COMPOSITIONS MODULATING CHROMATIN STRUCTURE FOR GRAFT VERSUS HOST DISEASE (GVHD) DANA-FARBER CANCER INSTITUTE, INC. (US) 2019-01-03 — — US disclosed
US-9840512-B2 Antidiabetic bicyclic compounds MERCK SHARP & DOHME CORP. (US) 2017-12-12 — — US disclosed
US-20160002255-A1 ANTIDIABETIC BICYCLIC COMPOUNDS MERCK SHARP & DOHME LLC 2016-01-07 — — US disclosed
EP-2958562-A1 ANTIDIABETIC BICYCLIC COMPOUNDS Merck Sharp & Dohme Corp. (US) 2015-12-30 — — EP disclosed
WO-2014130608-A1 ANTIDIABETIC BICYCLIC COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2014-08-28 — — WO disclosed
WO-2006091530-A2 COMBINATORIAL HYDROGEL FORMULATION TRANSFORM PHARMACEUTICALS, INC. (US) 2006-08-31 — — WO disclosed
US-20060188940-A1 Combinatorial hydrogel formulation TRANSFORM PHARMACEUTICALS, INC. 2006-08-24 — — US disclosed
US-20050276781-A1 Molecularly imprinted phosphate binders for therapeutic use UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. 2005-12-15 — — US disclosed
Send feedback